Antimicrobial Stewardship in China: Systems, Actions and Future Strategies.

Antimicrobial resistance (AMR) has become a serious global public health crisis, and AMR control has consequently become a priority in all countries. Specifically, the incidence of various common multidrug-resistant bacteria is high, and there are multiple problems concerning the irrational use of antimicrobial drugs. In the past decade, China has established a relatively comprehensive management system and technical support framework for antimicrobial stewardship, including regulations, guidelines, networks for the surveillance of AMR and antimicrobial consumption, and professional personnel training. In addition, the Ministry of Health has carried out a special campaign to promote the proper clinical use of antibiotics in medical institutions, which significantly improved outcomes. The use of antibacterial drugs without indication and the consumption of antibiotics have been significantly reduced. In consideration of the factors that contribute to AMR, the structure of the healthcare system in China, and the need for long-term sustaining efforts to control AMR, the strategy of "two steps and two hands" must be implemented to contain AMR. The first step is to generally promote the rational use of antimicrobial agents in order to promptly curb the rising momentum of resistance with high pressure from the government. The second step requires sustainable professional work with the implementation of precise AMR control. The "first hand" refers to the government-oriented active establishment and optimization of the system and infrastructure of rational antibiotic use and AMR control. The "second hand" refers to the cultivation of professional teams to ensure the establishment and development of sustainable processes in AMR control.

[1]  Chao Zhang,et al.  The professional status of infectious disease physicians in China: a nationwide cross-sectional survey. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  M. Akova,et al.  Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. , 2017, The Lancet. Infectious diseases.

[3]  Yonghong Xiao,et al.  China's national plan to combat antimicrobial resistance. , 2016, The Lancet. Infectious diseases.

[4]  Yonghong Xiao National action plan on antimicrobial resistance: a great blueprint based on "One Health" , 2016 .

[5]  Yonghong Xiao,et al.  Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach , 2016, Scientific Reports.

[6]  Yonghong Xiao,et al.  Epidemiology and characteristics of antibacterial resistance in China , 2016 .

[7]  Yonghong Xiao,et al.  Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities. , 2015, Microbes and infection.

[8]  Yonghong Xiao,et al.  Use and prescription of antibiotics in primary health care settings in China. , 2014, JAMA internal medicine.

[9]  G. Tomson,et al.  Varying High Levels of Faecal Carriage of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Rural Villages in Shandong, China: Implications for Global Health , 2014, PloS one.

[10]  Yonghong Xiao,et al.  Changes in Chinese Policies to Promote the Rational Use of Antibiotics , 2013, PLoS medicine.

[11]  Yong-hong Xiao Infections disease physician should be the backbone of antibacterial agent rational use , 2009 .

[12]  S. Nyberg,et al.  Association between Antimicrobial Consumption and Resistance in Escherichia coli , 2008, Antimicrobial Agents and Chemotherapy.

[13]  O. Cars,et al.  Strama--a Swedish working model for containment of antibiotic resistance. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.